| Ashley Rae Kann, PHARMD, BCCCP | |
|
216 S Country Club Ave, Brandon, SD 57005-6614 | |
| (701) 715-0533 | |
| Not Available |
| Full Name | Ashley Rae Kann |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Critical Care |
| Location | 216 S Country Club Ave, Brandon, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932811759 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835C0205X | Pharmacist - Critical Care | 6256 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Rae Kann, PHARMD, BCCCP 216 S Country Club Ave, Brandon, SD 57005-6614 Ph: (701) 715-0533 | Ashley Rae Kann, PHARMD, BCCCP 216 S Country Club Ave, Brandon, SD 57005-6614 Ph: (701) 715-0533 |
News Archive
Viking Systems, Inc. said today that it has increased its cash and liquidity position through the issuance of common stock. In a series of transactions from August 4, 2010 through September 30, 2010, the Company raised $1,171,117 by selling an aggregate of 3,665,335 shares of its common stock through its previously announced financing facility with Dutchess Opportunity Fund, II, LP.
Predicting how atherosclerosis, osteoporosis or cancer will progress or respond to drugs in individual patients is difficult.
Celgene Corporation today announced the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee will hold a review of the Company's new drug application (NDA) for pomalidomide at its meeting on November 8, 2012.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
In a newly released report comparing international usage of prescription drugs, Canada ranks thirteenth among 14 countries for cancer drugs launched within the last five years. The study, conducted for the UK Secretary of State for Health, compared 14 countries for their usage of 14 categories of prescription drugs to determine whether the UK is adequately providing for the health needs of its citizens.
› Verified 7 days ago
Jessica Ann Bebensee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 116 E Holly Blvd, Brandon, SD 57005 Phone: 605-582-6000 | |
Amy Schoeneman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 117 N Splitrock Blvd, Brandon, SD 57005 Phone: 605-367-2910 Fax: 605-367-2915 | |
James Nolz, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 313 E Seth St, Brandon, SD 57005 Phone: 605-359-5086 | |
Brad Rotert, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115 N Splitrock Blvd, Brandon, SD 57005 Phone: 605-367-2910 | |
Katie Melius, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115 N Splitrock Blvd, Brandon, SD 57005 Phone: 605-367-2910 Fax: 605-367-2915 | |
Anita Tigner, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 115 N Splitrock Blvd, Brandon, SD 57005 Phone: 605-367-2910 Fax: 605-367-2915 |